Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Roswell Park Cancer Institute
Case Comprehensive Cancer Center